Literature DB >> 33856636

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

Matthew Stevenson1, Ankita Srivastava1, Jenny Lee1, Christopher Hall1, Thomas Palaia1,2, Raymond Lau3, Collin Brathwaite4, Louis Ragolia5,6.   

Abstract

PURPOSE: Understanding the effects of Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) on adipose tissue physiology is important for the treatment of obesity-related metabolic disorders. By using robust mouse models of bariatric surgery that closely resemble those performed in humans, we can compare the effects of RYGB and VSG on adipose physiology in the absence of post-operative confounds such as diet and lifestyle changes.
MATERIALS AND METHODS: RYGB and VSG were compared using a diet-induced mouse model of obesity. High-fat diet (HFD) was administered post-operatively and changes to white and brown adipose tissue were evaluated, along with alterations to weight, glucose homeostasis, dyslipidemia, and insulin sensitivity.
RESULTS: After prolonged exposure to high-fat diet post-operatively, RYGB was effective in achieving sustained weight loss, while VSG unexpectedly accelerated weight gain rates. The resolution of obesity-related comorbidities such as glucose and insulin intolerance, dyslipidemia, and insulin sensitivity was improved after RYGB, but not for VSG. In RYGB, there were improvements to the function and health of white adipose tissue, enhanced brown adipose metabolism, and the browning of subcutaneous white adipose tissue, with no comparable changes seen for these factors after VSG. Some markers of systemic inflammation improved after both RYGB and VSG.
CONCLUSION: There are significantly different effects between RYGB and VSG when HFD is administered post-operatively and robust mouse models of bariatric surgery are used. RYGB resulted in lasting physiological and metabolic changes but VSG showed little difference from that of its sham-operated, DIO counterpart.

Entities:  

Keywords:  Adipose tissue; Bariatric surgery; Hypertrophy; Inflammation; Insulin sensitivity; Thermogenesis

Year:  2021        PMID: 33856636     DOI: 10.1007/s11695-021-05389-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  75 in total

1.  Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.

Authors:  Brooke E Bayham; Frank L Greenway; Drake E Bellanger; Carol E O'Neil
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

2.  Trends in Bariatric Surgery: Procedure Selection, Revisional Surgeries, and Readmissions.

Authors:  Anasooya Abraham; Sayeed Ikramuddin; Cyrus Jahansouz; Fahd Arafat; Nathanael Hevelone; Daniel Leslie
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

3.  Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study.

Authors:  Bestoun Ahmed; Wendy C King; William Gourash; Steven H Belle; Amanda Hinerman; Alfons Pomp; Greg Dakin; Anita P Courcoulas
Journal:  Surgery       Date:  2018-08-20       Impact factor: 3.982

4.  Severe anemia after Roux-en-Y gastric bypass: a cause for concern.

Authors:  Emily McCracken; G Craig Wood; Wesley Prichard; Bruce Bistrian; Christopher Still; Glenn Gerhard; David Rolston; Peter Benotti
Journal:  Surg Obes Relat Dis       Date:  2018-03-28       Impact factor: 4.734

5.  Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.

Authors:  G Nosso; E Griffo; M Cotugno; G Saldalamacchia; R Lupoli; G Pacini; G Riccardi; L Angrisani; B Capaldo
Journal:  Horm Metab Res       Date:  2016-01-20       Impact factor: 2.936

6.  Comparison between RYGB, DS, and VSG effect on glucose homeostasis.

Authors:  Mitchell S Roslin; Yuriy Dudiy; Joanne Weiskopf; Tanuja Damani; Paresh Shah
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

7.  Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates.

Authors:  Zhamak Khorgami; Saeed Shoar; Amin Andalib; Ali Aminian; Stacy A Brethauer; Philip R Schauer
Journal:  Surg Obes Relat Dis       Date:  2017-01-25       Impact factor: 4.734

8.  Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up.

Authors:  David Benaiges; Albert Goday; Jose M Ramon; Elisa Hernandez; Manuel Pera; Juan F Cano
Journal:  Surg Obes Relat Dis       Date:  2011-03-17       Impact factor: 4.734

9.  Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.

Authors:  Jenny H Lee; Quynh-Nhu Nguyen; Quang A Le
Journal:  Surg Obes Relat Dis       Date:  2016-01-21       Impact factor: 4.734

Review 10.  Bariatric surgery and long-term nutritional issues.

Authors:  Roberta Lupoli; Erminia Lembo; Gennaro Saldalamacchia; Claudia Kesia Avola; Luigi Angrisani; Brunella Capaldo
Journal:  World J Diabetes       Date:  2017-11-15
View more
  2 in total

1.  Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet.

Authors:  Ankita Srivastava; Matthew Stevenson; Jenny Lee; Christopher Hall; Thomas Palaia; Chaohui Lisa Zhao; Raymond Lau; Collin Brathwaite; Louis Ragolia
Journal:  Obes Surg       Date:  2022-04-14       Impact factor: 3.479

Review 2.  The role of obesity and bariatric surgery-induced weight loss in breast cancer.

Authors:  Margaret S Bohm; Laura M Sipe; Madeline E Pye; Matthew J Davis; Joseph F Pierre; Liza Makowski
Journal:  Cancer Metastasis Rev       Date:  2022-07-23       Impact factor: 9.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.